Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 71,580 | 0.1% | 92,736 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 53,959 | 0.1% | 95,966 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 54,713 | 0.1% | 104,215 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 65,158 | 0.1% | 102,736 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 73,282 | 0.1% | 102,876 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 112,230 | 0.2% | 106,760 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 112,854 | 0.2% | 107,375 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 101,989 | 0.2% | 124,124 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 103,379 | 0.2% | 117,705 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 91,958 | 0.2% | 111,740 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 83,236 | 0.2% | 115,840 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 101,989 | 0.2% | 124,124 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 89,619 | 0.2% | 124,214 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 87,779 | 0.2% | 127,424 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 72,717 | 0.2% | 123,013 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 85,227 | 0.2% | 122,028 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 76,853 | 0.1% | 121,695 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 74,696 | 0.1% | 123,427 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 70,895 | 0.1% | 126,930 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 61,972 | 0.1% | 130,980 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 64,823 | 0.1% | 134,179 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 75,433 | 0.2% | 134,755 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 82,430 | 0.2% | 132,174 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 54,541 | 0.2% | 111,698 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 40,404 | 0.1% | 107,606 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 34,351 | 0.1% | 121,611 | 6/30/2014 |
| 2014 Q1 | 4/24/2014 | 36,751 | 0.1% | 122,389 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 37,475 | 0.1% | 136,154 | 12/31/2013 |